Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 16, 2008Journal of Nuclear MedicineOpen Access

PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles

View Full Paper
Ask AI
Bookmark
Share

Authors

HLHa‐Young LeeZLZibo LiKCKai Chen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lee et al. (2008) studied this question.

synapsesocial.com/papers/6a86f5dd48ef9afcd2a251d2https://doi.org/10.2967/jnumed.108.051243
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging.1990 · 182 citations
  2. 2In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor Xenografts2004 · 345 citations
  3. 3Multivalent Effects of RGD Peptides Obtained by Nanoparticle Display2006 · 385 citations
  4. 4MicroPET: a high resolution PET scanner for imaging small animals1997 · 615 citations